This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by de Groote, P. Articles by Bauters, C. Search for Related Content PubMed PubMed Citation Articles by de Groote, P. Articles by Bauters, C.

B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure

Pascal de Groote, MD^*,*, Joël Dagorn, MD^*, Benoit Soudan, MD, Nicolas Lamblin, MD^*, Eugene McFadden, FRCPI, FACC and Christophe Bauters, MD, FACC^*

^* Service de Cardiologie C, Hôpital Cardiologique, Lille Cedex, France
Laboratoire d'endocrinologie, Clinique Linquette, CHRU, 59037 Lille Cedex, France
Thoraxcenter, Erasmus Medical Centre, Rotterdam, The Netherlands

View larger version (31K): [in a new window]   Figure 1 Kaplan-Meier survival curves in subgroups of patients divided according to cutoff values of plasma levels of B-type natriuretic peptide (BNP) and of percentage of maximal predicted VO2 (%VO2).